Literature DB >> 23541627

Pathophysiology of atherosclerosis plaque progression.

Kenichi Sakakura1, Masataka Nakano, Fumiyuki Otsuka, Elena Ladich, Frank D Kolodgie, Renu Virmani.   

Abstract

Atherosclerotic plaque rupture with luminal thrombosis is the most common mechanism responsible for the majority of acute coronary syndromes and sudden coronary death. The precursor lesion of plaque rupture is thought to be a thin cap fibroatheroma (TCFA) or "vulnerable plaque". TCFA is characterised by a necrotic core with an overlying thin fibrous cap (≤65 μm) that is infiltrated by macrophages and T-lymphocytes. Intraplaque haemorrhage is a major contributor to the enlargement of the necrotic core. Haemorrhage is thought to occur from leaky vasa vasorum that invades the intima from the adventitia as the intima enlarges. The early atherosclerotic plaque progression from pathologic intimal thickening (PIT) to a fibroatheroma is thought to be the result of macrophage infiltration. PIT is characterised by the presence of lipid pools which consist of proteoglycan with lipid insudation. The conversion of the lipid pool to a necrotic core is poorly understood but is thought to occur as a result of macrophage infiltration which releases matrix metalloproteinase (MMPs) along with macrophage apoptosis that leads to the formation of a acellular necrotic core. The fibroatheroma has a thick fibrous cap that begins to thin over time through macrophage MMP release and apoptotic death of smooth muscle cells converting the fibroatheroma into a TCFA. Other causes of thrombosis include plaque erosion which is less frequent than plaque rupture but is a common cause of thrombosis in young individuals especially women <50 years of age. The underlying lesion morphology in plaque erosion consists of PIT or a thick cap fibroatheroma. Calcified nodule is the least frequent cause of thrombosis, which occurs in older individuals with heavily calcified and tortious arteries.
Copyright © 2013 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23541627     DOI: 10.1016/j.hlc.2013.03.001

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  105 in total

1.  Increased size and cellularity of advanced atherosclerotic lesions in mice with endothelial overexpression of the human TRPC3 channel.

Authors:  Kathryn B Smedlund; Lutz Birnbaumer; Guillermo Vazquez
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 2.  Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis.

Authors:  Mingyi Wang; Soo Hyuk Kim; Robert E Monticone; Edward G Lakatta
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

Review 3.  Noninvasive Imaging of Atherosclerotic Plaque Progression: Status of Coronary Computed Tomography Angiography.

Authors:  Veit Sandfort; Joao A C Lima; David A Bluemke
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

Review 4.  Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

Review 5.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

Review 6.  Cardiovascular inflammation: RNA takes the lead.

Authors:  Colton R Martens; Shyam S Bansal; Federica Accornero
Journal:  J Mol Cell Cardiol       Date:  2019-03-14       Impact factor: 5.000

7.  Coronary Plaque Progression and Regression in Asymptomatic African American Chronic Cocaine Users With Obstructive Coronary Stenoses: A Preliminary Study.

Authors:  Veit Sandfort; David A Bluemke; Jose Vargas; Jeffrey A Brinker; Gary Gerstenblith; Thomas Kickler; Gang Zheng; Ji Li; Shaoguang Chen; Hong Lai; Elliot K Fishman; Shenghan Lai
Journal:  J Addict Med       Date:  2017 Mar/Apr       Impact factor: 3.702

Review 8.  The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach.

Authors:  Frederick O Cope; Bonnie Abbruzzese; James Sanders; Wendy Metz; Kristyn Sturms; David Ralph; Michael Blue; Jane Zhang; Paige Bracci; Wiam Bshara; Spencer Behr; Toby Maurer; Kenneth Williams; Joshua Walker; Allison Beverly; Brooke Blay; Anirudh Damughatla; Mark Larsen; Courtney Mountain; Erin Neylon; Kaeli Parcel; Kapil Raghuraman; Kevin Ricks; Lucas Rose; Akhilesh Sivakumar; Nicholas Streck; Bryan Wang; Christopher Wasco; Larry S Schlesinger; Abul Azad; Murugesan V S Rajaram; Wael Jarjour; Nicholas Young; Thomas Rosol; Amifred Williams; Michael McGrath
Journal:  Nucl Med Biol       Date:  2015-12-03       Impact factor: 2.408

9.  Coronary CT Angiography: Variability of CT Scanners and Readers in Measurement of Plaque Volume.

Authors:  Rolf Symons; Justin Z Morris; Colin O Wu; Amir Pourmorteza; Mark A Ahlman; João A C Lima; Marcus Y Chen; Marissa Mallek; Veit Sandfort; David A Bluemke
Journal:  Radiology       Date:  2016-09-16       Impact factor: 11.105

10.  Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosis.

Authors:  Julia Collin; Mario Gössl; Yoshiki Matsuo; Rebecca R Cilluffo; Andreas J Flammer; Darrell Loeffler; Ryan J Lennon; Robert D Simari; Daniel B Spoon; Raimund Erbel; Lilach O Lerman; Sundeep Khosla; Amir Lerman
Journal:  Int J Cardiol       Date:  2014-11-26       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.